SNBL USA Announces Newly Appointed Experts To Acute Radiation Syndrome (ARS) Advisory Board
Everett, WA – March 5, 2015 - SNBL USA, the experts in preclinical research, announced today the members of its newly-formed ARS Advisory Board, comprised of leading experts in the field of radiation biology and research. The Advisory Board will serve to provide strategic vision and scientific guidance to SNBL USA’s ARS program.
“We are excited and honored to announce the formation of this Board as we broaden our ARS program,” said Dr. Koichiro Fukuzaki, SNBL USA President and CEO. “These distinguished members represent years of technical and scientific expertise, providing immeasurable value to SNBL as we continue our commitment to lead the industry in this important area of research and development.”
The members of SNBL USA's ARS Advisory Board include:
• Nicholas Dainiak, MD, FACP, Clinical Professor of Medicine, Departments of Internal Medicine and Therapeutic Radiology, Yale University School of Medicine
• George E. Georges, MD, Associate Member, Fred Hutchinson Cancer Research Center, Associate Professor, University of Washington
• Martin Hauer-Jensen, MD, PhD, FACS, Professor of Pharmaceutical Sciences, Surgery, and Pathology, Director, Division of Radiation Health, Associate Dean for Research, College of Pharmacy, University of Arkansas for Medical Sciences
• Alan Liss, PhD, pharmaceutical industry consultant, formerly a Director of the Medical Countermeasures Initiative in the Office of the Commissioner at the FDA
• Thomas J. MacVittie, PhD, Professor, Radiation Oncology and Pathology, University of Maryland School of Medicine
• John E. Moulder, PhD, Professor of Radiation Biology, Department of Radiation Oncology, Medical College of Wisconsin
“The formal launch of our ARS Advisory Board enforces our commitment to working with clients in the development of innovative treatments for various forms of ARS," said Dr. Ronald Manning, SNBL USA senior technical director of model development. "These highly respected and influential thought leaders in the radiation field will position SNBL USA to contribute in the development of vital ARS medical countermeasures.”
For additional information regarding SNBL services and capabilities, contact us at +1.425.322.1950 or info@snblusa.com. About SNBL USA, Ltd.
Headquartered in Everett, Wash., SNBL USA offers a unique range of safety assessment services to fulfill its commitment to help free patients from suffering. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, SNBL USA offers programs ranging from regulatory toxicology to customized study designs in multiple drug classes (biologics, small molecules, oligonucleotides, vaccines).
Help employers find you! Check out all the jobs and post your resume.
“We are excited and honored to announce the formation of this Board as we broaden our ARS program,” said Dr. Koichiro Fukuzaki, SNBL USA President and CEO. “These distinguished members represent years of technical and scientific expertise, providing immeasurable value to SNBL as we continue our commitment to lead the industry in this important area of research and development.”
The members of SNBL USA's ARS Advisory Board include:
• Nicholas Dainiak, MD, FACP, Clinical Professor of Medicine, Departments of Internal Medicine and Therapeutic Radiology, Yale University School of Medicine
• George E. Georges, MD, Associate Member, Fred Hutchinson Cancer Research Center, Associate Professor, University of Washington
• Martin Hauer-Jensen, MD, PhD, FACS, Professor of Pharmaceutical Sciences, Surgery, and Pathology, Director, Division of Radiation Health, Associate Dean for Research, College of Pharmacy, University of Arkansas for Medical Sciences
• Alan Liss, PhD, pharmaceutical industry consultant, formerly a Director of the Medical Countermeasures Initiative in the Office of the Commissioner at the FDA
• Thomas J. MacVittie, PhD, Professor, Radiation Oncology and Pathology, University of Maryland School of Medicine
• John E. Moulder, PhD, Professor of Radiation Biology, Department of Radiation Oncology, Medical College of Wisconsin
“The formal launch of our ARS Advisory Board enforces our commitment to working with clients in the development of innovative treatments for various forms of ARS," said Dr. Ronald Manning, SNBL USA senior technical director of model development. "These highly respected and influential thought leaders in the radiation field will position SNBL USA to contribute in the development of vital ARS medical countermeasures.”
For additional information regarding SNBL services and capabilities, contact us at +1.425.322.1950 or info@snblusa.com. About SNBL USA, Ltd.
Headquartered in Everett, Wash., SNBL USA offers a unique range of safety assessment services to fulfill its commitment to help free patients from suffering. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, SNBL USA offers programs ranging from regulatory toxicology to customized study designs in multiple drug classes (biologics, small molecules, oligonucleotides, vaccines).
Help employers find you! Check out all the jobs and post your resume.